These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 6167377)

  • 21. Influence of p53 expression on sensitivity of cancer cells to bleomycin.
    Lee YS; Yoon S; Park MS; Kim JH; Lee JH; Song CW
    J Biochem Mol Toxicol; 2010; 24(4):260-9. PubMed ID: 20135637
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Up-regulation of antioxidant enzymes and coenzyme Q(10) in a human oral cancer cell line with acquired bleomycin resistance.
    Yen HC; Li SH; Majima HJ; Huang YH; Chen CP; Liu CC; Tu YC; Chen CW
    Free Radic Res; 2011 Jun; 45(6):707-16. PubMed ID: 21486114
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of bleomycin A5 with calmodulin inhibitor on the proliferation of S-180 cells in vitro].
    Zhang HQ; He NG; Xue SB
    Zhongguo Yao Li Xue Bao; 1990 Sep; 11(5):470-3. PubMed ID: 1718143
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bleomycin: revival of an old drug.
    Mir LM; Tounekti O; Orlowski S
    Gen Pharmacol; 1996 Jul; 27(5):745-8. PubMed ID: 8842674
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Strand scission of deoxyribonucleic acid by neocarzinostatin, auromomycin, and bleomycin: studies on base release and nucleotide sequence specificity.
    Takeshita M; Kappen LS; Grollman AP; Eisenberg M; Goldberg IH
    Biochemistry; 1981 Dec; 20(26):7599-606. PubMed ID: 6173064
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bleomycin as a possible synchronizing agent for human tumor cells in vivo.
    Barranco SC; Luce JK; Romsdahl MM; Humphrey RM
    Cancer Res; 1973 Apr; 33(4):882-7. PubMed ID: 4121285
    [No Abstract]   [Full Text] [Related]  

  • 27. Response of mammalian cells following treatment with bleomycin and 1,3-bis(2-chloroethyl)-1-nitrosourea during plateau phase.
    Barranco SC; Novak JK; Humphrey RM
    Cancer Res; 1973 Apr; 33(4):691-4. PubMed ID: 4121282
    [No Abstract]   [Full Text] [Related]  

  • 28. Establishment of three bleomycin-resistant human carcinoma cell lines and their cross-resistance to other antitumor agents.
    Urade M; Sugi M; Miyazaki T
    Cancer; 1988 Apr; 61(8):1501-7. PubMed ID: 2450630
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Involvement of the cellular vacuolar system with the cytotoxicity of bleomycin-like agents.
    Lazo JS; Schisselbauer JC; Herring GM; Kennedy KA
    Cancer Commun; 1990; 2(2):81-6. PubMed ID: 1695520
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction of ionizing radiation with the topoisomerase I poison camptothecin in growing V-79 and HeLa cells.
    Hennequin C; Giocanti N; Balosso J; Favaudon V
    Cancer Res; 1994 Apr; 54(7):1720-8. PubMed ID: 8137287
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The mode of action of bleomycin-cell kinetic investigations (author's transl)].
    Ganzer U
    Laryngol Rhinol Otol (Stuttg); 1978 Mar; 57(3):177-86. PubMed ID: 77461
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bleomycin analogues preferentially cleave at the transcription start sites of actively transcribed genes in human cells.
    Chen JK; Yang D; Shen B; Murray V
    Int J Biochem Cell Biol; 2017 Apr; 85():56-65. PubMed ID: 28167289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of bleomycin on rapidly proliferating epidermis. A comparative investigation using micro-flow fluorometry, H3Tdr incorporation and a stathmokinetic method (colcemid).
    Clausen OP
    Virchows Arch B Cell Pathol; 1975 Dec; 19(4):337-48. PubMed ID: 54977
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Enhancement of antitumor activity of bleomycin A5 in mouse sarcoma 180 cells in vitro and in vivo by verapamil].
    He NG; Zhang HQ; Wang RH; Yang XL; Xue SB
    Zhongguo Yao Li Xue Bao; 1990 Jul; 11(4):381-4. PubMed ID: 1716815
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytotoxic and antitumor properties of bleomycin and several of its metal complexes.
    Rao EA; Saryan LA; Antholine WE; Petering DH
    J Med Chem; 1980 Dec; 23(12):1310-8. PubMed ID: 6161253
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytotoxic effect of pingyangmycin on cultured KB cells.
    Tai KW; Chang YC; Chou LS; Chou MY
    Oral Oncol; 1998 May; 34(3):219-23. PubMed ID: 9692057
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased clastogenicity and decreased inhibition of DNA synthesis by neocarzinostatin and tallysomycin in ataxia telangiectasia lymphoid cells.
    Cohen MM; Simpson SJ
    Mutat Res; 1983 Apr; 112(2):119-28. PubMed ID: 6188042
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Studies on the mechanism of drug resistance in tumor cells and a new antitumor antibiotic].
    Tanaka N
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2666-73. PubMed ID: 6210060
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synergetic cytotoxicity of bleomycin and polyhydric alcohols: DNA strand breakage evaluated by "comet assay".
    Kasamatsu T; Kohda K; Kawazoe Y
    Biol Pharm Bull; 1996 Apr; 19(4):632-5. PubMed ID: 9132173
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cysteine proteinase inhibitors and bleomycin-sensitive and -resistant cells.
    Morris G; Mistry JS; Jani JP; Sebti SM; Lazo JS
    Biochem Pharmacol; 1991 Jun; 41(11):1559-66. PubMed ID: 1710457
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.